EIF2AK3 and myeloid sarcoma: In vitro and in vivo studies have shown that activation of the PERK-eIF2α pathway leads to activation of NF-κB in oligodendrocytes and suggest neuroprotective effects of PERK signaling in MS and experimental allergic encephalitis (EAE), which is the animal model of MS [330].